Australian Clinical Labs Limited Share Price
Equities
ACL
AU0000148496
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 AUD | -0.41% | -0.82% | -16.26% |
03-05 | Australia shares inch lower as miners weigh; GDP data in focus | RE |
02-28 | Australian Clinical Labs Falls 11% After Trimming Interim Dividend on Lower H1 FY24 EPS | MT |
Sales 2024 * | 683M 443M 35.49B | Sales 2025 * | 711M 461M 36.94B | Capitalization | 485M 315M 25.2B |
---|---|---|---|---|---|
Net income 2024 * | 29M 18.81M 1.51B | Net income 2025 * | 38M 24.64M 1.97B | EV / Sales 2024 * | 0.77 x |
Net Debt 2024 * | 39.25M 25.45M 2.04B | Net Debt 2025 * | 17.81M 11.55M 925M | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
12.6
x | Employees | 5,115 |
Yield 2024 * |
3.54% | Yield 2025 * |
4.67% | Free-Float | 55.78% |
Latest transcript on Australian Clinical Labs Limited
1 day | -0.41% | ||
1 week | -0.82% | ||
Current month | -10.04% | ||
1 month | -10.04% | ||
3 months | -20.39% | ||
6 months | -8.68% | ||
Current year | -16.26% |
Managers | Title | Age | Since |
---|---|---|---|
Melinda McGrath
CEO | Chief Executive Officer | - | 31/12/14 |
James Davison
DFI | Director of Finance/CFO | - | 31/12/14 |
Tony Landgren
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Alscher
CHM | Chairman | 56 | 31/12/14 |
Leanne Rowe
BRD | Director/Board Member | 67 | 27/04/21 |
Director/Board Member | - | 22/08/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
01/05/24 | 2.42 | -0.41% | 296 828 |
30/04/24 | 2.43 | -0.82% | 94,036 |
29/04/24 | 2.45 | -0.41% | 144,588 |
26/04/24 | 2.46 | -1.20% | 246,118 |
24/04/24 | 2.49 | +2.05% | 198,250 |
Delayed Quote Australian S.E., May 01, 2024 at 07:10 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.26% | 316M | |
-14.25% | 85.35B | |
+14.46% | 81.95B | |
+9.37% | 28.99B | |
-11.40% | 16.98B | |
-0.36% | 16.85B | |
+0.22% | 15.35B | |
+4.32% | 12.42B | |
+32.69% | 12.19B | |
-31.40% | 11.89B |
- Stock Market
- Equities
- ACL Stock